Salbutamol potentiates the relaxant effects of selective phopshodiesterase inhibitors on guinea pig isolated trachea

Fundamental and Clinical Pharmacology

Volumn 10, Issue 4, 1996, Pages 356-367

  Planquois, J M ^a   Ruffin Morin, Y ^a   Lagente, V ^b   Payne, A N ^a   Dahl, S G ^a  

^a Institut de Recherche Jouveinal   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

cAMP; Guinea pig trachealis; Phosphodiesterase inhibitors; Salbutamol; Smoot muscle; 2 agonist

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HISTAMINE; INDOMETACIN; ISOPRENALINE; MILRINONE; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; SALBUTAMOL; SIGUAZODAN; THEOPHYLLINE; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SELECTIVITY; GUINEA PIG; ISOLATED ORGAN; MALE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SMOOTH MUSCLE TONE; TRACHEA MUSCLE;

EID: 0029739823     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00587.x     Document Type: Article

References (53)

1. Barnes PJ, Cuss FMC. Biochemistry of airway smooth muscle. Clin Resp Physiol 1986;22(suppl 7):191
2. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol Sci 1990;11:150-5
3. Beavo JA, Conti M, Heaslip RJ. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 1994;46:399-405
4. Belvisi MG, Miura M, Peters MJ et al. Effect of isoenzyme-selective cyclic nucleotide phosphodiesterase inhibitors on human tracheal smooth muscle tone. Br J Pharmacol 1992;107:53p
5. Brunnee T, Engelstätter R, Steinijans VW, Kunkel G. Bronchodilatatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor in patients with asthma. Eur Respir J 1992;5:982-5
6. Butcher RW, Sutherland EW. Adenosine 3′,5′-phosphate in biological materials. J Biol Chem 1962;237:1244-50
7. 2-adrenoceptor agonist salmeterol on airway hyperresponsiveness in patients with mild asthma. New Engl J Med 1992;327: 1198-203
8. Cieslinski LB, Reeves ML, Torphy TJ. Cyclic nucleotide phosphodiesterases (PDEs) in canine and human tracheal smooth muscle. FASEB J 1988;2:A1065
9. Cortijo J, Bou J, Beleta J, Cardelus J, Llenas J, Morcillo E, Gristwood RW. Investigation into the role of phosphodiesterase IV in bronchorelaxation including studies with human bronchus. Br J Pharmacol 1993;108:562-8
10. De Boer J, Philpott AJ, Van Amdsterdam RGM, Shahid M, Zaagsma J, Nicholson CD. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol 1992;106:1028-34
11. Dent G, Giembycz MA, Rabe KF, Barnes PJ. Inhibition of eosinophil cyclic nucleotide PDE activity and zymosan-stimulated respiratory burst by 'type IV'-opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors. Br J Pharmacol 1991;103:1339-46
12. Drummond GI, Perrot-Yee S. Enzymatic hydrolysis of adenosine 3′,5′-phosphoric acid. J Biol Chem 1961;236:1126-9
13. Foster RW, Rakshi K, Carpenter JR, Small RC. Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volunteers during a methacholine challenge test. Br J Clin Pharmacol 1992; 34:527-34
14. Giembycz MA, Barnes PJ. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachea by AH 21-132: relevance to the spasmolytic and spasmogenic action of AH21-132 in the intact tissue. Biochem Pharmacol 1991;42:663-77
15. Giembycz MA, Raeburn D. Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Autonom Pharmacol 1991;11: 345-98
16. Giembycz MA, Dent G. Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma. Clin Exp Allergy 1992;22:337-44
17. Giembycz MA, Belvisi MG, Miura M, Peters MJ, Yacoub M, Barnes PJ. Soluble cyclic nucleotide phosphodiesterases in human trachea and the mechanical effect of isoenzyme-selective inhibitors. Am Rev Resp Dis 1992;145:A378
18. Hall IP, Donaldson J, Hill SJ. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors. Biochem Pharmacol 1990;39:1357-63
19. m cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J Pharmacol Exp Ther 1989;251:199-206
20. Heaslip RJ, Lombardo LJ, Golankiewicz JM, Ilsemann BA, Evans BD, Sickels BD, Mudrick JK, Bagli J, Weichman BM. Phosphodiesterase-IV inhibition respiratory muscle relaxation and bronchodilation by WAY-PDA-641. J Pharmacol Exp Ther 1994;268:888-96
21. Ho PPK, Wang LY, Towner RD, Hayes SJ, Pollock D, Bowling N, Wyss V, Panetta JA. Cardiovascular effect and stimulus-dependent inhibition of Superoxide generation from human neutrophils by tibenelast, 5,6-diethoxybenzo(b)thiophene-2-carboxylic acid, sodium salt (LY 186655). Biochem Pharmacol 1990;40:2085-92
22. Ind PW, Barnes PJ, Durham, SR, Kay AB. Propanolol-induced bronchoconstriction in asthma: beta-receptor blockade and mediator release. Am Rev Respir Dis 1984;129:10A
23. Israel E, Mthur PN, Tashkin D, Drazen JM. LY186655 prevents bronchospasm in asthma of moderate severity. Chest 1988;94:71S
24. Jiang H, Colbran JL, Francis SH, Corbin JD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 1992;267:1015-9
25. Komas N, Lugnier C, Stoclet JC. Endothelium-dependent and independent relaxation of rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 1991;104: 495-503
26. Muller B, Lugnier C, Stocler JC. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. J Cardiovasc Pharmacol 1990;16: 796-803
27. Nair KG. Purification and properties of 3′,5′-cyclic nucleotide phosphodiesterase from dog heart. Biochemistry 1966; 5:150-7
28. Nicholson CD, Challiss RAJ, Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleolide phosphodiesterase isoenzymes. Trends Pharmacol Sci 1991;12:19-26
29. 2-agonists in asthma. New Engl J Med 1992;327:1204-8
30. Planquois JM, Ruffin-Morin Y, Junien JL, Moodley I. Potentiation of relaxant effect of selective phosphodiesterase inhibitors on guinea pig trachea by threshold concentrations of salbutamol. Fundam Clin Pharmacol 1995;9:75
31. Polli J, Kincaid RL. Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J Neurosci 1994;14(3):1251-61
32. Quian Y, Naline E, Karlsson JA, Raeburn D, Advenier C. Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside. Br J Pharmacol 1993;109:774-8
33. Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen H. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization. Am J Physiol 1993;264:L458-64
34. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, Karlsson JA. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 1994;113:1423-31
35. Robiscsek SA, Blanchard DK, Djeu JY, Krzanowski JJ, Szentivanyi A, Poison JB. Multiple high-affinity cyclic AMP-phosphodiesterase in human T-lymphocytes. Biochem Pharmacol 1991;42:869-77
36. Rodger IW, Small RC. Pharmacology of airway smooth muscle. In: Barnes PJ, Page CP, eds. Handbook of Experimental Pharmacology. Berlin: Springer-Verlag, 1991;98:107-42
37. Samuelsson B, Golddyne M, Granström E, Hamberg M, Hammarström, Malmsten C. Prostaglandins and thromboxanes. Ann Rev Biochem 1978;47:997-1029
38. Schramm CM, Grunstein MM. Assessement of signal transduction mechanisms regulating airway smooth muscle contractility. Am Physiol Soc 1992;262:L119-39
39. Sears MR, Taylor DR, Print CG, Lake DC, Li Q, Flannery EM, Yates DM, Lucas MK, Herbison GP. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336: 1391-6
40. Sette C, Iona S, Conti M. The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J Biol Chem 1994a;56:9245-52
41. Sette C, Vicini E, Conti M. The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J Biol Chem 1994b; 269:18271-4
42. Shahid M, Van Amsterdam RGM, De Boer J, Ten Berge RE, Nicholson CD, Zaagsma J. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br J Pharmacol 1991;104:471-7
43. Shahid M, Philpott AJ, De Boer J, Zaagsma J, Nicholson CD. Cyclic nucleotide phosphodiesterase (PDE) isoenzyme activities in human peripheral bronchi. Br J Pharmacol 1992;105:129p
44. Silver PJ, Hamel LT, Perrone MH, Bently RG, Bushover CR, Evans DB. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle. Eur J Pharmacol 1988;150:85-94
45. Souness JE, Carter CM, Diocee BK, Hassall GA, Wood LJ, Turner NC. Characterization of guinea pig eosinophil phosphodiesterase activity. Biochem Pharmacol 1991;42: 937-45
46. Tallarida RJ, Murray RB. Manual of pharmacological calculations with computer programs. New York, Heidelberg, Berlin: Springer-Verlag, 1986
47. Tomkinson A, Karlsson JA, Raeburn D. Comparison of the effect of selective inhibitors of phosphodiesterase type III and IV in airway smooth muscle with differing β-adrenoceptor subtypes. Br J Pharmacol 1993;108:57-61
48. Torphy TJ. Action of mediators on airway smooth muscle: functional antagonism as a mechanism for bronchodilator drugs. In: O'Donnell SR, Persson CGA, eds. New Anti-asthma Drug. Basel: Birkhauser, 1988:37
49. Torphy TJ, Undem BJ. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 1988;46: 512-23
50. m cyclic AMP phosphodiesterase in intact canine trachea by SKF 94836: mechanical and biochemical response. J Pharmacol Exp Ther 1988;246:843-50
51. Torphy TJ, Undem BJ, Cieslinski LB, Luttman MA, Reeves ML, Hay DWP. Identification characterisation and functional role of phosphodiesterase isozymes in human airways smooth muscle. J Pharmacol Exp Ther 1993;265: 1213-23
52. Underwood DC, Matthews JK, Osborn RR, Novak LB, Torphy TJ. The significance of β-adrenergic activity on the inhibitory effects of rolipram against early and late phase response to antigen in the guinea pig. Am Rev Respir Dis 1992;145:A392
53. 1-histaminergic activation stimulates phosphatidylinositol labeling in rabbit aorta. Eur J Pharmacol 1983;90:457p